Scalp angiosarcoma treated with linear accelerator-based boron neutron capture therapy: A report of two patients

Masunaga, 2014, The dependency of compound biological effectiveness factors on the type and the concentration of administered neutron capture agents in boron neutron capture therapy, Springerplus, 3, 10.1186/2193-1801-3-128 Detta, 2009, L-amino acid transporter-1 and boronophenylalanine-based boron neutron capture therapy of human brain tumors, Cancer Res, 69, 2126, 10.1158/0008-5472.CAN-08-2345 Higuchi, 2019, Characterization of the expression of LAT1 as a prognostic indicator and a therapeutic target in renal cell carcinoma, Sci Rep, 9, 10.1038/s41598-019-53397-7 Kaira, 2012, Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer, Br J Cancer, 107, 632, 10.1038/bjc.2012.310 Mishima, 1989, Treatment of malignant melanoma by single thermal neutron capture therapy with melanoma-seeking 10B-compound, Lancet, 334, 388, 10.1016/S0140-6736(89)90567-9 Hirose, 2021, Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan ((10)B) for recurrent or locally advanced head and neck cancer (JHN002): An open-label phase II trial, Radiother Oncol, 155, 182, 10.1016/j.radonc.2020.11.001 Nakamura, 2021, Neutron flux evaluation model provided in the accelerator-based boron neutron capture therapy system employing a solid-state lithium target, Sci Rep, 11, 10.1038/s41598-021-87627-8 Nakamura, 2019, Characterization of the relationship between neutron production and thermal load on a target material in an accelerator-based boron neutron capture therapy system employing a solid-state Li target, PLoS ONE, 14, e0225587, 10.1371/journal.pone.0225587 Nakamura, 2017, Evaluation of radioactivity in the bodies of mice induced by neutron exposure from an epi-thermal neutron source of an accelerator-based boron neutron capture therapy system, Proc Jpn Acad Ser B Phys Biol Sci, 93, 821, 10.2183/pjab.93.051 Koshi, 2015, L-type amino acid transporter-1 and CD98 expression in bone and soft tissue tumors, Pathol Int, 65, 460, 10.1111/pin.12323 Patel, 2015, Angiosarcoma of the scalp and face: the Mayo Clinic experience, JAMA Otolaryngol Head Neck Surg, 141, 335, 10.1001/jamaoto.2014.3584 Ward, 2003, Radiation therapy for angiosarcoma, Head Neck, 25, 873, 10.1002/hed.10276 Fujisawa, 2014, Chemoradiotherapy with taxane is superior to conventional surgery and radiotherapy in the management of cutaneous angiosarcoma: a multicentre, retrospective study, Br J Dermatol, 171, 1493, 10.1111/bjd.13110 Ohguri, 2005, Angiosarcoma of the scalp treated with curative radiotherapy plus recombinant interleukin-2 immunotherapy, Int J Radiat Oncol Biol Phys, 61, 1446, 10.1016/j.ijrobp.2004.08.008 Hata, 2018, Radiation Therapy for Angiosarcoma of the Scalp: Total Scalp Irradiation and Local Irradiation, Anticancer Res, 38, 1247 Hiratsuka, 2020, Long-term outcome of cutaneous melanoma patients treated with boron neutron capture therapy (BNCT), J Radiat Res, 61, 945, 10.1093/jrr/rraa068 Fukuda, 1999, Pharmacokinetics of 10B-p-boronophenylalanine in tumors, skin and blood of melanoma patients: a study of boron neutron capture therapy for malignant melanoma, Melanoma Res, 9, 75, 10.1097/00008390-199902000-00010 Sato, 2018, J Nucl Sci Technol, 55, 684, 10.1080/00223131.2017.1419890 Chadwick, 1999, A consistent set of neutron kerma coefficients from thermal to 150 MeV for biologically important materials, Med Phys, 26, 974, 10.1118/1.598601 ICRU, Tissue substitutes in radiation dosimetry and measurement. ICRU report 44. 1989. Hu, 2021, Radiat Oncol, 16, 243, 10.1186/s13014-021-01968-2 Nakamura, 2019, Dependence of neutrons generated by 7Li(p, n) reaction on Li thickness under free-air condition in accelerator-based boron neutron capture therapy system employing solid-state Li target, Phys Med, 58, 121, 10.1016/j.ejmp.2019.02.010 Clement, 2012, ICRP publication 118: ICRP statement on tissue reactions and early and late effects of radiation in normal tissues and organs–threshold doses for tissue reactions in a radiation protection context, Ann ICRP, 41, 1, 10.1016/j.icrp.2012.06.009 De Felice, 2017, Radiation therapy and serum salivary amylase in head and neck cancer, Oncotarget, 8, 90496, 10.18632/oncotarget.18763 Kawabata, 2003, The early successful treatment of glioblastoma patients with modified boron neutron capture therapy. Report of two cases, J Neurooncol, 65, 159, 10.1023/B:NEON.0000003751.67562.8e